Copyright
©The Author(s) 2025.
World J Gastroenterol. May 28, 2025; 31(20): 100192
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.100192
Published online May 28, 2025. doi: 10.3748/wjg.v31.i20.100192
Table 1 Baseline characteristics of patients who underwent endoscopic minor papilla intervention procedures for symptomatic pancreatic diseases
Characteristics | Value |
Demographics (n = 43) | |
Sex | |
Male | 31 (72.1) |
Female | 12 (27.9) |
Age (year) | 48.7 ± 12.7 |
Abdominal pain symptom (n = 43) | |
Duration of abdominal pain (months) | 24 (0.5-206) |
Pain requiring hospitalization | 30 (73.2) |
Chronic recurrent pain requiring analgesic drugs | 26 (61.9) |
Narcotics | 9 (34.6) |
NSAIDs | 17 (65.4) |
Concurrent cholangitis/bile stasis (n = 28) | |
Cholangitis | 10 (24.4) |
Bile stasis | 18 (43.9) |
Indications for EMPI (n = 43)1 | |
OCP | 32 (74.4) |
OCP with obstruction of MPD or pancreatic sphincter | 27 (62.8) |
OCP due to a downstream MPD stone or stricture | 22 (51.2)2 |
OCP due to a pancreatic sphincter stricture | 2 (4.7) |
OCP due to a tumorous stricture | 3 (7.0) |
OCP with reverse-Z type of MPD | 4 (9.3)3 |
OCP with dorsal duct stones | 1 (2.3)4 |
Pancreas divisum | 8 (18.6)5 |
IPMN | 3 (7.0) |
Classification of APD (n = 21) | |
Long-type | 13 (61.9) |
Short-type | 8 (38.1) |
Laboratory tests (n = 42) | |
Elevated serum amylase or lipase | 6 (14.3) |
Abnormal liver enzyme | 12 (28.6) |
- Citation: Ren X, Qu YP, Xia T, Tang XF. Technical success, clinical efficacy, and safety of endoscopic minor papilla interventions for symptomatic pancreatic diseases. World J Gastroenterol 2025; 31(20): 100192
- URL: https://www.wjgnet.com/1007-9327/full/v31/i20/100192.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i20.100192